Urolog. pro Praxi, 2005; 2: 78-79

Hypertenze jako rizikový faktor u karcinomu ledviny

Ing. Gabriela Janoutová1, MUDr. Jiřina Koutná2, MUDr. František Beška CSc3, Ing. Luděk Čížek1, Ing. Jiří Lorenc3, prof. MUDr. Vladimír Janout CSc1
1 Ústav preventivního lékařství, LF UP v Olomouci
2 Onkologické oddělení, M-VIA NOVA Ltd., Zábřeh
3 Krajské pracoviště Národního onkologického registru, FNsP Ostrava

Hypertenze je uváděna jako jeden z rizikových faktorů pro vznik karcinomu ledviny. V databázi preventivních onkologických prohlídek z okresu Šumperk byl formou studie případů a kontrol ověřován tento vztah na souboru 221 nemocných s karcinomem ledviny a 30 329 kontrolních zdravých osob. Bylo zjištěno mírně zvýšené odds ratio pro systolický i diastolický krevní tlak, a to jak u celého souboru, tak i při jeho rozdělení na muže a ženy. Hodnoty odds ratio u žen byly výrazně vyšší než u mužů. Práce potvrdila, že existuje souvislost mezi hypertenzí a rizikem vzniku karcinomu ledviny, i když se nedá vyloučit primární účinek antihypertenzivní léčby.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janoutová G, Koutná J, Beška F, Čížek L, Lorenc J, Janout V. Hypertenze jako rizikový faktor u karcinomu ledviny. Urol. praxi. 2005;6(2):78-79.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chow WH, Gridley G, Fraumen JF Jr, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343: 1305-1311. Go to original source... Go to PubMed...
    2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000 - cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. International Agency for Research on Cancer, Lyon, 2001.
    3. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134: 942-947. Go to original source... Go to PubMed...
    4. Lijinsky W, Reuber MD. Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrate, to 344 rats. Toxicol Ind Health 1987; 3: 413-422. Go to original source... Go to PubMed...
    5. Máchová L, Janout V, Koutná J, Beška F, Čížek L, Lorenc J. Preventive oncologic check-ups in the district Šumperk, 1975-1986: the description of a database. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146: 99-101. Go to original source... Go to PubMed...
    6. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales. II. Urological disease, hypertension, obesity and hormonal factors. Cancer Causes Control 1992; 3: 323-331. Go to original source... Go to PubMed...
    7. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni Jr JF. Renal cancer. In: Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention. Oxford University Press 1996: 1142-1155.
    8. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, Schlehofer B, Pommer W, Niwa S, Adami HO. International renal-cell cancer study. VIII. Role of diuretics, other antihypertensive medications and hypertension. Int J Cancer 1995; 63: 216-221. Go to original source... Go to PubMed...
    9. Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma. A second look. Cancer 1995; 75: 2552-2557. Go to original source...
    10. Raynor WJ Jr, Shekelle RB, Rossof AH, Maliza C, Paula O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol 1981; 113: 371-377. Go to original source... Go to PubMed...
    11. ÚZIS ČR, Aktuální informace č.1, 2004.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.